Discussion on: Long-Term Impact of Saroglitazar on Advanced Hepatic Fibrosis and Metabolic Dysfunction in MASLD patients: A Two-Year Case Series

Discussion: Scholarly discussion on any scientific article is very important for the advancement of science. We strongly suggest all readers and authors to participate in such activities. Comment posting facility is available at the end of this page. Comment should meet the minimum standard of scientific discussion. Personal communication, personal attack, abusive language, etc are not allowed and comments will be moderated.

Article Title
Long-Term Impact of Saroglitazar on Advanced Hepatic Fibrosis and Metabolic Dysfunction in MASLD patients: A Two-Year Case Series
Authored by

Naresh Dang
Max Super Speciality Hospital, Patparganj, New Delhi, India.

Meenakshi Jain
Max Super Speciality Hospital, Patparganj, New Delhi, India.

DOI or Article Link

https://doi.org/10.9734/ajcrmh/2025/v8i1252

Leave a Comment